Thrombomodulin-modified thrombin generation after in vivo recombinant factor VIII treatment in severe hemophilia A

Haematologica

Volumn 93, Issue 9, 2008, Pages 1351-1357

  Dielis, Arne W J H ^a,c   Balliël, Wolfgang M R ^b   Van Oerle, René ^b   Hermens, Wim T ^a   Spronk, Henri M H ^a   Ten Cate, Hugo ^a   Hamulyák, Karly ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Coagulation factor VIII; Hemophilia A; Thrombin generation; Thrombomodulin

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 8; THROMBIN; THROMBOMODULIN; THROMBOPLASTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; HEMOPHILIA A; HUMAN; IN VIVO CULTURE; MALE; THROMBIN TIME;

ADOLESCENT; ADULT; AGED; FACTOR VIII; HEMOPHILIA A; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RECOMBINANT PROTEINS; THROMBIN; THROMBOMODULIN;

EID: 50849110526     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.13039     Document Type: Article

References (23)

1. Lusher JM. First and second generation recombinant factor VIII concentrates in previously untreated patients: recovery, safety, efficacy, and inhibitor development. Semin Thromb Hemost 2002;28:273-6.
2. Hemker HC, Giesen P, AIDieri R, Regnault V, de Smed E, Wagenvoord R, et al. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 2002;32:249-53.
3. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003;33:4-15.
4. Beltran-Miranda CP, Khan A, Jaloma-Cruz AR, Laffan MA. Thrombin generation and phenotypic correlation in haemophilia A. Haemophilia 2005;11:326-34.
5. Dargaud Y, Bordet JC, Francillon S, Negrier C. Haemophilia patients exhibit prolonged coagulation time but normal lag time of thrombin generation test: are these results really discordant? Thromb Haemost 2007;97:675-6.
6. Dargaud Y, Beguin S, Lienhart A, Al Dieri R, Trzeciak C, Bordet JC, et al. Evaluation of thrombin generation capacity in plasma from patients with haemophilia A and B. Thromb Haemost 2005;93:475-80.
7. Trossaert M, Regnault V, Sigaud M, Boisseau P, Fressinaud E, Lecompte T. Mild haemophilia A with factor VIII assay discrepancy: using thrombin generation assay to assess the bleeding phenotype. J Thromb Haemost 2008;6:486-93.
8. Barrowcliffe TW. Monitoring haemophilia severity and treatment: new or old laboratory tests? Haemophilia 2004;10:109-14.
9. Siegemund T, Petros S, Siegemund A, Scholz U, Engelmann L. Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in plateletrich plasma. Thromb Haemost 2003;90:781-6.
10. Butenas S, van't Veer C, Mann KG. "Normal" thrombin generation. Blood 1999;94:2169-78.
11. Radtke KP, Griffin JH, Riceberg J, Gale AJ. Disulfide bond-stabilized factor VIII has prolonged factor VIIIa activity and improved potency in whole blood clotting assays. J Thromb Haemost 2007;5:102-8.
12. Rugeri L, Beguin S, Hemker C, Bordet JC, Fleury R, Chatard B, et al. Thrombin-generating capacity in patients with von Willebrand's disease. Haematologica 2007;92:1639-46.
13. Bassus S, Wegert W, Krause M, Escuriola-Ettinghausen C, Siegemund A, Petros S, et al. Platelet-dependent coagulation assays for factor VIII efficacy measurement after substitution therapy in patients with haemophilia A. Platelets 2006;17:378-84.
14. Brummel-Ziedins K, Undas A, Orfeo T, Gissel M, Butenas S, Zmudka K, et al. Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor composition. J Thromb Haemost 2008;6:104-10.
15. Siegemund A, Petros S, Siegemund T, Scholz U, Seyfarth HJ, Engelmann J. The endogenous thrombin potential and high levels of coagulation factor VIII, factor IX and factor XI. Blood Coagul Fibrinolysis 2004;15:214-4.
16. Regnault V, Beguin S, Lecompte T. Calibrated automated thrombin generation in frozen-thawed plateletrich plasma to detect hypercoagulability. Pathophysiol Haemost Thromb 2003;33:23-9.
17. Matsumoto T, Shima M, Takeyama M, Yoshida K, Tanaka I, Sakurai Y, et al. The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay. J Thromb Haemost 2006;4:377-84.
18. Lewis SJ, Stephens E, Florou G, Macartney NJ, Hathaway LS, Knipping J, et al. Measurement of global haemostasis in severe haemophilia A following factor VIII infusion. Br J Haematol 2007; 138:775-82.
19. Dargaud Y, Lienhart A, Meunier S, Hequet O, Chavanne H, Chamouard V, et al. Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision. Haemophilia 2005;11:552-8.
20. Salvagno GL, Astermark J, Ekman M, Franchini M, Guidi GC, Lippi G, et al. Impact of different inhibitor reactivities with commercial factor VIII concentrates on thrombin generation. Haemophilia 2007;13:51-6.
21. Varadi K, Turecek PL, Schwarz HP. Thrombin generation assay and other universal tests for monitoring haemophilia therapy. Haemophilia 2004;10:17-21.
22. Dielis AW, Castoldi E, Spronk HM, van Oerle R, Hamulyák K, ten Cate H, et al. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. J Thromb Haemost 2008;6:125-31.
23. Dargaud Y, Trzeciak MC, Bordet JC, Ninet J, Negrier C. Use of calibrated automated thrombinography +/-thrombomodulin to recognise the prothrombotic phenotype. Thromb Haemost 2006;96:562-7.